City firm switches pills for injections for MS sufferers

Posted: Published on January 27th, 2014

This post was added by Dr Simmons

City firm switches pills for injections for MS sufferers

6:30am Monday 27th January 2014 in News By Pete Hughes, Reporter. Call me on 01865 425431

AN OXFORD drug company has developed the first pill to treat Multiple Sclerosis that can be prescribed to the majority of sufferers.

Until now people with the most common form of MS, relapsing and remitting (RRMS), have only been able to medicate with injections.

But on Wednesday Oxford firm Genzyme, based at the Oxford Business Park in Cowley, had its new pill Aubagio approved by the National Institute for Clinical Excellence (NICE).

Jenna Mahoney, a spokesman for the MS Society, said: This is excellent news for people with MS.

There are a number of treatments for this sort of MS but they are all injectable, and this offers people an alternative for the first time.

She said that in a recent MS Society survey, a huge proportion of sufferers said they would prefer to take a tablet to an injection.

Aubagio, the trade name for chemical teriflunomide, slows down the degenerative effects of the disease.

In Multiple Sclerosis, the immune system starts attacking the coating around the bodys nerve cells, which stops them from working.

Read this article:
City firm switches pills for injections for MS sufferers

Related Posts
This entry was posted in MS Treatment. Bookmark the permalink.

Comments are closed.